buyModerate
Bvf Partners L P/il bought $6.2M of RPTX
owner at Repare Therapeutics Inc.. 1,227,301 shares at an average of $5.09, traded Nov 15, 2023, filed Nov 17, 2023.
Conviction score
43Value
$6.2M
1,227,301 shares
Holdings after
548,938
+26% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +25Trade size$6.2M at market
- +6Relative to holdingsHoldings up 26%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- 0Track recordToo few past buys to judge (2 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000921895-23-002669, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 15, 2023 | POpen-market purchase Common Shares, no par value | +493,337 | $5.00 | $2.5M | 5,155,739 | Nov 17, 2023 |
| Nov 15, 2023 | POpen-market purchase Common Shares, no par value | +390,507 | $5.00 | $2.0M | 4,182,664 | Nov 17, 2023 |
| Nov 15, 2023 | POpen-market purchase Common Shares, no par value | +47,712 | $5.00 | $239k | 532,795 | Nov 17, 2023 |
| Nov 16, 2023 | POpen-market purchase Common Shares, no par value | +153,693 | $5.38 | $827k | 5,309,432 | Nov 17, 2023 |
| Nov 16, 2023 | POpen-market purchase Common Shares, no par value | +125,909 | $5.38 | $678k | 4,308,573 | Nov 17, 2023 |
| Nov 16, 2023 | POpen-market purchase Common Shares, no par value | +16,143 | $5.38 | $87k | 548,938 | Nov 17, 2023 |
Related signals
Other insiders at Repare Therapeutics Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | Repare Therapeutics Inc. | Steve Forte EVP, CHIEF FINANCIAL OFFICER | $7,848 6,884 shares | -11% | |
| 23Weak | Repare Therapeutics Inc. | Maria Koehler EVP, CHIEF MEDICAL OFFICER | $4,099 3,596 shares | -2% | |
| 17Weak | Repare Therapeutics Inc. | Steve Forte EVP, CHIEF FINANCIAL OFFICER | $7,449 1,614 shares | -3% | |
| 10Weak | Repare Therapeutics Inc. | Maria Koehler EVP, CHIEF MEDICAL OFFICER | $3,718 800 shares | -0% | |
| 10Weak | Repare Therapeutics Inc. | Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER | $3,999 860 shares | -1% | |
| 20Weak | Repare Therapeutics Inc. | Lloyd Mitchell Segal PRESIDENT AND CEO | $24k 5,141 shares | -5% | |
| 17Weak | Repare Therapeutics Inc. | Steve Forte EVP, CHIEF FINANCIAL OFFICER | $12k 2,475 shares | -6% | |
| 10Weak | Repare Therapeutics Inc. | Maria Koehler EVP, CHIEF MEDICAL OFFICER | $7,000 1,500 shares | -1% | |
| 26Weak | Repare Therapeutics Inc. | Lloyd Mitchell Segal PRESIDENT AND CEO | $37k 7,950 shares | -9% | |
| 10Weak | Repare Therapeutics Inc. | Michael Zinda EVP, CHIEF SCIENTIFIC OFFICER | $6,305 1,350 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.